Editas Medicine (EDIT) PT Raised to $77 at Chardan Capital Markets
Tweet Send to a Friend
Chardan Capital Markets analyst Geulah Livshits raised the price target on Editas Medicine (NASDAQ: EDIT) to $77.00 (from $55.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
